Dr. Alice Scott Mims, MD

Dr. Mims practices at OSU Internal Medicine in Columbus, Ohio.

Dr. Mims' NPI, 1699962084, was assigned on September 28, 2007. Dr. Mims graduated from Medical University of South Carolina College of Medicine in 2005. Dr. Mims holds Ohio license 35.092964.

Dr. Mims' primary practice is OSU Internal Medicine, at 460 W 10th Ave, Columbus, OH 43210 in Franklin County. The practice phone is (614) 293-2229.

Dr. Mims' primary practice is OSU Internal Medicine in Columbus, Ohio. Dr. Mims is also affiliated with Ohio State University Hospital. The medical group on file is Ohio State University Physicians. Dmand AI also links Dr. Mims to 1 more hospital, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Mims practices, 2 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Mims' primary specialty in the NPI Registry, under taxonomy code 207RH0000X. The record also lists hematology. Dmand AI has Dr. Mims' licenses on file in 4 states: Ohio, Iowa, North Carolina and South Carolina.

CMS data shows 315 Medicare services from Dr. Mims across 5 procedure codes in 2024, for 119 Medicare patients. Medicare paid $24,841 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 119 Medicare patients who saw Dr. Mims in 2024. The largest group is 65 to 74, with 58 patients. 75% of them have high blood pressure, and 68% have high cholesterol. 11% are also on Medicaid. Their average risk score is 3.13, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Mims' median patient age at 67, with 48% women.

In 2024, Dr. Mims wrote 846 Medicare Part D claims for 97 patients. 48% of them were for generic drugs. CMS names the drug for 560 of them, across 21 drugs with 11 or more claims each, at $6,063,401 in total drug cost. In 2023, CMS named 462 claims across 19 drugs.

Dr. Mims accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Mims as offering telehealth.

Dmand AI links 105 papers to Dr. Mims, published from 2012 to 2025. 2021 was the busiest year, with 15. The most frequent topics are Leukemia, Myeloid, Acute, Antineoplastic Agents and Antineoplastic Combined Chemotherapy Protocols. Dr. Mims has published most often in Blood Adv. Dr. Mims' most frequent co-authors are John C. Byrd, MD, James Stewart Blachly, MD and Karilyn T.m. Larkin, MD.

Dmand AI links Dr. Mims to 10 clinical trials, 5 of them phase 1 studies. 4 are still active or recruiting. Conditions studied include Leukemia, Myeloid, Acute, Leukemia, Myeloid and Myelodysplastic Syndromes. National Cancer Institute (NCI) sponsors the most, 4.

CMS Open Payments shows 92 general payments to Dr. Mims from 19 drug and device companies from 2018 to 2025. Consulting fees make up the largest share, 75% of the total. Abbvie Inc. paid the most, $16,420.

Dr. Mims graduated from Medical University of South Carolina College of Medicine in 2005.